September 18, 2017 — Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU ...
Balloon Catheter
This channel includes news and new technology innovations for angioplasty balloon catheters (PTA). These are used in arteries with atherosclerotic lesions to compress the plaque expand the artery lumen to reopen occluded or heavily stenosed atherosclerotic lesions. Balloons are often used in combination with a stent to prop the treated vessel segment open. In addition to plain old balloon angioplasty (POBA), this section includes news about drug-coated balloon (DCB), valvuloplasty balloons and specialty cutting balloon.
September 13, 2017 — Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference ...
September 13, 2017 — Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
August 29, 2017 — C.R. Bard Inc. announced the Lutonix 035 Drug Coated Balloon PTA Catheter (DCB) has been granted ...
August 15, 2017 — Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and ...
July 26, 2017 — The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market approval ...
June 28, 2017 — Philips Healthcare and Spectranetics Corp. announced they have entered into a definitive merger ...
June 12, 2017 – Med Alliance announced completion on schedule of patient enrollment in the first-in-man (FIM) study of ...
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports of ...
This video, provided by Spectranetics, demonstrates how to deploy the Bridge Occlusion Balloon used to seal accidental ...
May 17, 2017 — Contego Medical LLC announced recently that it has received CE Marking of its Vanguard IEP Peripheral ...
April 26, 2017 — Boston Scientific announced results from the RANGER SFA trial for the Ranger Paclitaxel-Coated PTA Ball ...
March 9, 2017 — Medtronic plc announced the launch of the IN.PACT BTK study to evaluate the effectiveness of a drug ...
February 8, 2017 — Medtronic plc announced receipt of an investigational device exemption (IDE) from the U.S. Food and ...
December 6, 2016 — The Spectranetics Corp. announced in late November that its Stellarex 0.014-inch drug-coated ...